11 – 20 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
A human antithrombin isoform dampens inflammatory responses and protects from organ damage during bacterial infection
(
- Contribution to journal › Article
- 2018
-
Mark
Promoter-associated proteins of EPAS1 identified by enChIP-MS – A putative role of HDX as a negative regulator
(
- Contribution to journal › Article
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
(
- Contribution to journal › Article
- 2017
-
Mark
Cell-Type-Specific Gene Programs of the Normal Human Nephron Define Kidney Cancer Subtypes
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological WHO2015 classification
(
- Contribution to journal › Article
- 2016
-
Mark
CYP1A2 - a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
(
- Contribution to journal › Article
-
Mark
Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer.
(
- Contribution to journal › Article
- 2015
-
Mark
Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
(
- Contribution to journal › Article
-
Mark
Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.
(
- Contribution to journal › Article
-
Mark
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article